Record $500M Donation Boosts Dementia Research at Karolinska Institutet

Karolinska Institutet, a leading medical university in Sweden, has received a donation of SEK 538 million (approximately $500 million USD) – the largest gift ever made to a Swedish university in modern times – to bolster research into dementia and other debilitating diseases. The donation comes from the estate of Leif Lundblad, the inventor of the bank-note dispenser found in ATMs, who passed away in October 2025 at the age of 87.

Lundblad, a long-time supporter of medical research at Karolinska Institutet, specifically designated the funds for research into neurodegenerative diseases, with a primary focus on Alzheimer’s disease. Additional funding will be directed towards research on chronic pain and autoimmune diseases, reflecting Lundblad’s broad philanthropic interests. According to a press release from the institute, Lundblad frequently expressed a desire to “solve the mystery of Alzheimer’s.”

A Transformative Gift for Dementia Research

The donation is structured to maximize its impact. SEK 500 million will be allocated as research grants, awarded competitively to researchers at Karolinska Institutet. A further SEK 30 million will establish a professorship dedicated to dementia research and SEK 8 million will fund an innovation prize. This multifaceted approach aims to foster both fundamental scientific discovery and the translation of research into practical applications.

This substantial influx of funding arrives at a critical juncture. Globally, the prevalence of dementia is rising rapidly, driven by aging populations. While significant progress has been made in understanding the underlying pathology of diseases like Alzheimer’s, effective treatments remain elusive. The focus of research at Karolinska Institutet will include earlier diagnosis, the development of novel therapies, and a deeper understanding of the mechanisms driving these diseases. The institute’s Center for Alzheimer Research is well-positioned to leverage this funding, integrating preclinical and clinical research to address the disease across its entire spectrum.

Annika Östman Wernerson, president of Karolinska Institutet, described the gift as “incredibly generous” and expressed gratitude for Lundblad’s “intention, and commitment.” Jenny Löhr, unit manager at the institute, added that Lundblad’s generosity “will make a large impact on Swedish dementia research over a long time.”

Beyond the pursuit of a cure, the donation will support research into preventative measures and early detection strategies. Increasingly, scientists recognize that the biological changes associated with dementia can begin decades before the onset of noticeable symptoms. Identifying individuals at risk and intervening early could potentially delay or even prevent the development of the disease. This preventative focus, coupled with the pursuit of innovative treatments, represents a comprehensive approach to tackling the growing global challenge of dementia.

The donation from Leif Lundblad represents a significant boost not only for Karolinska Institutet but for the broader field of dementia research. Researchers will be watching closely to see how this unprecedented level of funding translates into tangible progress in understanding, treating, and ultimately preventing these devastating diseases.